A leading data aggregator revolutionizing healthcare research
Headquartered in the US and founded with the aim to revolutionize the healthcare research landscape, our customer has played a pivotal role in supporting life sciences businesses with the use of real-world data. Through enhancing study protocol design, optimizing study feasibility, and streamlining site selection, they have made significant strides in their domain. By providing accurate and timely data, they empower researchers to drive scientific discovery and improve patient lives.
Federated research network for life sciences
The primary objective of this data aggregator was to provide more granular access to patient data, including sensitive EU data, for their life sciences customers. However, their latest solution, which enables life science customers to run their own models and analytics on the data, was hindered by GDPR compliance issues. This obstacle was not just a hurdle to their service expansion but was also a concern raised by their life sciences customers for over a year.
Fully federated and GDPR compliant model training at the edge
To tackle this problem, they worked with Apheris to offer a solution through fully federated machine learning and statistics at the edge, ensuring no sensitive EU data left the hospital environments during the training phase.
Apheris' solution featured key attributes including computational access governance, asset policies, and the non-movement of data, critical for regulatory compliance:
Non-movement of data: a critical aspect in meeting GDPR compliance and enabling ML workloads to run on EU data.
Computational access governance: the data remains secured within partner hospitals, and the data aggregator permits only privacy-preserving computations to be executed.
Asset policies: simple and scalable approach to define who can do what, ensuring only permitted computations are run on the sensitive data.
These features facilitated control over data usage, preserved data privacy, and ensured only anonymous results were returned to the user.
This made it possible to provide granular computational access to EU data. As a result, life science customers could train models on EU data for the first-time. The steps to validate a pre-trained model on EU data reduced from eight to four, enabling faster and more accurate model validation with EU data.
Driving efficiency, ensuring compliance, and enhancing customer satisfaction
Adopting Apheris led to several notable benefits:
Streamlined process: An 8-step process reduced to 4, enabling faster and more accurate model validation with EU data. Model training on EU data was a reality for the first time.
Regulatory compliance: EU data made accessible with granular computational access for the data aggregator’s customers, compliant with GDPR.
Customer satisfaction, increased revenue: By fulfilling 12 months of customer requests and addressing the GDPR issue, model training on EU data became a reality for the first time, unlocking a significant revenue opportunity
Unlocking the value of sensitive data
This healthcare data aggregator's experience demonstrates how Apheris can help businesses unlock the full potential of their data assets in a secure, efficient, and compliant manner.
Are you ready to unlock more value from your data?
Get in touch today!